Neuromodulation flies in the face of modern psychiatry. It can significantly improve mental health without drugs. It allows us to stimulate or inhibit activity in precise regions of the brain using electricity, magnetism or ultrasound. 

Motif Neurotech is pioneering minimally invasive implants to precisely deliver neuromodulation for mental health. In this special episode, Matias joins Empath Ventures’ Brom Rector to interview Jacob Robinson, an entrepreneurial scientist who leveraged his academic research to start Motif Neurotech. 

PsyMed Ventures and Empath Ventures invested in Motif’s latest seed round. Motif's implantable device stimulates a region of the brain associated with depression. Other applications being explored include Alzheimer's disease, PTSD and ADHD.

Neuromodulation is still early but holds great promise as a paradigm shift in psychiatry and even human augmentation–unlocking the full potential of the brain.

Credits: 

Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky & Greg Kubin
Produced by Jonathan A. Davis,  Nico V. Rey & Caitlin Ner

Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank and Temperance by Eltham House